Clinical significance of lipid profile in systemic lupus erythematosus patients: Relation to disease activity and therapeutic potential of drugs-Reference-Cited by-同舟云学术

Clinical significance of lipid profile in systemic lupus erythematosus patients: Relation to disease activity and therapeutic potential of drugs

Published:2017-04 Issue:2 Volume:39 Page:93-98
ISSN:1110-1164
Container-title:The Egyptian Rheumatologist
language:en
Short-container-title:The Egyptian Rheumatologist

Author:

Ali Abdalla Mayada,Mostafa El Desouky Soha,Sayed Ahmed Amira

Publisher

Elsevier BV

Subject

Rheumatology

Reference35 articles.

1. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study;Manzi;Am J Epidemiol,1997

2. Risk factors for coronary artery disease in patients with systemic lupus erythematosus;Petri;Am J Med,1992

3. Chylomicron metabolism is markedly altered in systemic lupus erythematosus;Borba;Arthritis Rheum,2000

4. Long term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy;Borba;J Rheumatol,2001

5. Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia;Nuttall;Rheumatology (Oxford),2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy;Renal Failure;2024-08-30

2. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis;Lupus Science & Medicine;2024-03

3. Cardiac manifestations in patients with systemic lupus erythematosus and rheumatoid arthritis: Relation to long-term use of hydroxychloroquine;The Egyptian Rheumatologist;2024-01

4. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge;Therapeutic Advances in Musculoskeletal Disease;2022-01

5. The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis;Autoimmunity Reviews;2021-09